Back To Results

Research

July 09, 2019

Cracking the Sugar Code and Why It's Relevant to Psoriatic Disease

Episode 28

If you haven't heard about the glycome and glycan biomarkers, here's your chance to hear Dr. Emanual Maverakis, a dermatologist and physician investigator with the Departments of Dermatology, Medical Microbiology and Immunology at University of California, Davis discuss the altered glycan theory of autoimmunity and how glycan biomarkers may someday be used for the diagnosis and treatment of immune mediated diseases such as psoriasis.

Share
Related Items

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorMy Psoriasis Team logo

Copyright © 1996-2020 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.